Takeda Pharmaceutical Co Ltd (NYSE:TAK)
$ 13.02 -0.04 (-0.31%) Market Cap: 40.86 Bil Enterprise Value: 68.74 Bil PE Ratio: 40.31 PB Ratio: 0.88 GF Score: 68/100

Q3 2024 Takeda Pharmaceutical Co Ltd Earnings Presentation Transcript

Feb 01, 2024 / 10:30AM GMT
Release Date Price: $14.38 (-1.51%)
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot